These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 36192

  • 41. Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?
    Fleissner A, Seifert R, Schneider K, Eckert W, Fuisting B.
    Eur Arch Psychiatry Neurol Sci; 1987; 237(1):8-15. PubMed ID: 3480800
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Delusional misidentification and platelet monoamine oxidase.
    Barton JL, Chaparala S, Barton ES, Jackson IV, Davis LG.
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Effect of nomifensine on platelet monoamine oxidase activity in chronic schizophrenic patients.
    Filinger EJ.
    Gen Pharmacol; 1989 Apr; 20(6):821-2. PubMed ID: 2591711
    [Abstract] [Full Text] [Related]

  • 47. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.
    Wyatt RJ, Murphy DL, Belmaker R, Cohen S, Donnelly CH, Pollin W.
    Science; 1973 Mar 02; 179(4076):916-8. PubMed ID: 4687789
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Endogenous modulation of monoamine oxidase in schizophrenic and normal humans.
    Becker RE, Giambalvo CT.
    Am J Psychiatry; 1982 Dec 02; 139(12):1567-70. PubMed ID: 7149055
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients.
    Domino EF, Khanna SS.
    Am J Psychiatry; 1976 Mar 02; 133(3):323-6. PubMed ID: 943955
    [Abstract] [Full Text] [Related]

  • 52. Platelet monoamine oxidase activity and schizophrenia.
    Meltzer HY, Arora RC, Babar R, Jackman H, Nasr S, Pscheidt G, Smith M, Strahilevitz M.
    Arch Gen Psychiatry; 1980 Mar 02; 37(3):357. PubMed ID: 7362423
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Platelet monoamine oxidase activity in schizophrenic families - kinetic aspects.
    Koide Y, Sääf J, Wahlund LO, Roos SB, Wetterberg L.
    Clin Genet; 1981 May 02; 19(5):405-9. PubMed ID: 7296931
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.
    Propping P, Friedl W.
    Psychopharmacology (Berl); 1979 Nov 02; 65(3):265-72. PubMed ID: 117498
    [Abstract] [Full Text] [Related]

  • 59. Platelet MAO activity and long-term outcome in schizophrenia and schizoaffective disorder.
    Malas KL, van Kammen DP.
    Am J Psychiatry; 1983 Jun 02; 140(6):794-6. PubMed ID: 6846644
    [Abstract] [Full Text] [Related]

  • 60. Platelet MAO in schizophrenics: relationship to symptomatology and neuroleptics.
    Paik IH, Lee C, Kim CE.
    Biol Psychiatry; 1988 Jan 01; 23(1):93-5. PubMed ID: 2892539
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.